Literature DB >> 30816548

TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.

Wen Liu1, Xiang Chen1, Yanqi He1, Yihao Tian2, Liu Xu1, Yanbin Ma1, Pengchao Hu1, Ke Su3, Zhenyu Luo3, Lei Wei1, Jingwei Zhang4.   

Abstract

Lung cancer is the leading cause of cancer‑associated mortality worldwide. Tumor necrosis factor α (TNF‑α) is an important cytokine in the tumor microenvironment that serves a function in the balance of cell survival and cell death pathways. Our previous studies indicated that hypoxia‑inducible factor 1α (HIF‑1α) acts downstream of TNF‑α in MCF‑7 luminal breast cancer cells. However, whether vasodilator‑stimulated phosphoprotein (VASP) is implicated in the direct regulation of HIF‑1α in response to TNF‑α in lung cancer remains unknown. In vitro studies were performed using A549 and H226 lung carcinoma cells and in vivo studies of tumor xenograft models were performed to investigate the effects of TNF‑α. The results demonstrated that TNF‑α decreased VASP expression by upregulating the expression of HIF‑1α to inhibit A549 cell proliferation and adhesion. Inhibition of transplanted tumor growth was associated with downregulation of VASP expression in nude mice. Bioinformatics analysis indicated that expression levels of VASP or HIF‑1α lead to differential outcomes of overall survival in lung carcinoma. These results suggest that the HIF‑1α/VASP signaling pathway serves an important function in the regulation of TNF‑α‑induced suppression of A549 cell proliferation and xenograft growth. This may improve our understanding of the antitumor effect of TNF‑α.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30816548     DOI: 10.3892/or.2019.7026

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells.

Authors:  Zuhier A Awan; Shareefa A AlGhamdi; Nabil A Alhakamy; Solomon Z Okbazghi; Mohamed A Alfaleh; Shaimaa M Badr-Eldin; Hibah M Aldawsari; Mohammed A S Abourehab; Hani Z Asfour; Shadi A Zakai; Mohammad W Alrabia; Aya A Negm; Mohamed A El-Moselhy; Sara S Sharkawi; Waleed Y Rizg
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism.

Authors:  Fangfang Hao; Jinliang Chen; Jinnan Wu; Xin Ge; Xuedong Lv; Dongmei Zhang; Jianrong Chen
Journal:  Can Respir J       Date:  2022-04-11       Impact factor: 2.130

3.  Network Pharmacology Approach Reveals the Potential Immune Function Activation and Tumor Cell Apoptosis Promotion of Xia Qi Decoction in Lung Cancer.

Authors:  Song Zhang; Yun Wang
Journal:  Med Sci (Basel)       Date:  2019-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.